Cargando…

Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis

PURPOSE: We evaluated the diagnostic performance of histogram analysis of data from a combination of dynamic susceptibility contrast (DSC)-MRI and dynamic contrast-enhanced (DCE)-MRI for quantitative differentiation between central nervous system lymphoma (CNSL) and high-grade glioma (HGG), with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Murayama, Kazuhiro, Nishiyama, Yuya, Hirose, Yuichi, Abe, Masato, Ohyu, Shigeharu, Ninomiya, Ayako, Fukuba, Takashi, Katada, Kazuhiro, Toyama, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Magnetic Resonance in Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760232/
https://www.ncbi.nlm.nih.gov/pubmed/28515410
http://dx.doi.org/10.2463/mrms.mp.2016-0113
_version_ 1783291348269400064
author Murayama, Kazuhiro
Nishiyama, Yuya
Hirose, Yuichi
Abe, Masato
Ohyu, Shigeharu
Ninomiya, Ayako
Fukuba, Takashi
Katada, Kazuhiro
Toyama, Hiroshi
author_facet Murayama, Kazuhiro
Nishiyama, Yuya
Hirose, Yuichi
Abe, Masato
Ohyu, Shigeharu
Ninomiya, Ayako
Fukuba, Takashi
Katada, Kazuhiro
Toyama, Hiroshi
author_sort Murayama, Kazuhiro
collection PubMed
description PURPOSE: We evaluated the diagnostic performance of histogram analysis of data from a combination of dynamic susceptibility contrast (DSC)-MRI and dynamic contrast-enhanced (DCE)-MRI for quantitative differentiation between central nervous system lymphoma (CNSL) and high-grade glioma (HGG), with the aim of identifying useful perfusion parameters as objective radiological markers for differentiating between them. METHODS: Eight lesions with CNSLs and 15 with HGGs who underwent MRI examination, including DCE and DSC-MRI, were enrolled in our retrospective study. DSC-MRI provides a corrected cerebral blood volume (cCBV), and DCE-MRI provides a volume transfer coefficient (K(trans)) for transfer from plasma to the extravascular extracellular space. K(trans) and cCBV were measured from a round region-of-interest in the slice of maximum size on the contrast-enhanced lesion. The differences in t values between CNSL and HGG for determining the most appropriate percentile of K(trans) and cCBV were investigated. The differences in K(trans), cCBV, and K(trans)/cCBV between CNSL and HGG were investigated using histogram analysis. Receiver operating characteristic (ROC) analysis of K(trans), cCBV, and K(trans)/cCBV ratio was performed. RESULTS: The 30th percentile (C30) in K(trans) and 80th percentile (C80) in cCBV were the most appropriate percentiles for distinguishing between CNSL and HGG from the differences in t values. CNSL showed significantly lower C80 cCBV, significantly higher C30 K(trans), and significantly higher C30 K(trans)/C80 cCBV than those of HGG. In ROC analysis, C30 K(trans)/C80 cCBV had the best discriminative value for differentiating between CNSL and HGG as compared to C30 K(trans) or C80 cCBV. CONCLUSION: The combination of K(trans) by DCE-MRI and cCBV by DSC-MRI was found to reveal the characteristics of vascularity and permeability of a lesion more precisely than either K(trans) or cCBV alone. Histogram analysis of these vascular microenvironments enabled quantitative differentiation between CNSL and HGG.
format Online
Article
Text
id pubmed-5760232
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Japanese Society for Magnetic Resonance in Medicine
record_format MEDLINE/PubMed
spelling pubmed-57602322018-01-19 Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis Murayama, Kazuhiro Nishiyama, Yuya Hirose, Yuichi Abe, Masato Ohyu, Shigeharu Ninomiya, Ayako Fukuba, Takashi Katada, Kazuhiro Toyama, Hiroshi Magn Reson Med Sci Major Paper PURPOSE: We evaluated the diagnostic performance of histogram analysis of data from a combination of dynamic susceptibility contrast (DSC)-MRI and dynamic contrast-enhanced (DCE)-MRI for quantitative differentiation between central nervous system lymphoma (CNSL) and high-grade glioma (HGG), with the aim of identifying useful perfusion parameters as objective radiological markers for differentiating between them. METHODS: Eight lesions with CNSLs and 15 with HGGs who underwent MRI examination, including DCE and DSC-MRI, were enrolled in our retrospective study. DSC-MRI provides a corrected cerebral blood volume (cCBV), and DCE-MRI provides a volume transfer coefficient (K(trans)) for transfer from plasma to the extravascular extracellular space. K(trans) and cCBV were measured from a round region-of-interest in the slice of maximum size on the contrast-enhanced lesion. The differences in t values between CNSL and HGG for determining the most appropriate percentile of K(trans) and cCBV were investigated. The differences in K(trans), cCBV, and K(trans)/cCBV between CNSL and HGG were investigated using histogram analysis. Receiver operating characteristic (ROC) analysis of K(trans), cCBV, and K(trans)/cCBV ratio was performed. RESULTS: The 30th percentile (C30) in K(trans) and 80th percentile (C80) in cCBV were the most appropriate percentiles for distinguishing between CNSL and HGG from the differences in t values. CNSL showed significantly lower C80 cCBV, significantly higher C30 K(trans), and significantly higher C30 K(trans)/C80 cCBV than those of HGG. In ROC analysis, C30 K(trans)/C80 cCBV had the best discriminative value for differentiating between CNSL and HGG as compared to C30 K(trans) or C80 cCBV. CONCLUSION: The combination of K(trans) by DCE-MRI and cCBV by DSC-MRI was found to reveal the characteristics of vascularity and permeability of a lesion more precisely than either K(trans) or cCBV alone. Histogram analysis of these vascular microenvironments enabled quantitative differentiation between CNSL and HGG. Japanese Society for Magnetic Resonance in Medicine 2017-05-18 /pmc/articles/PMC5760232/ /pubmed/28515410 http://dx.doi.org/10.2463/mrms.mp.2016-0113 Text en © 2017 Japanese Society for Magnetic Resonance in Medicine This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Major Paper
Murayama, Kazuhiro
Nishiyama, Yuya
Hirose, Yuichi
Abe, Masato
Ohyu, Shigeharu
Ninomiya, Ayako
Fukuba, Takashi
Katada, Kazuhiro
Toyama, Hiroshi
Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis
title Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis
title_full Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis
title_fullStr Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis
title_full_unstemmed Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis
title_short Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis
title_sort differentiating between central nervous system lymphoma and high-grade glioma using dynamic susceptibility contrast and dynamic contrast-enhanced mr imaging with histogram analysis
topic Major Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760232/
https://www.ncbi.nlm.nih.gov/pubmed/28515410
http://dx.doi.org/10.2463/mrms.mp.2016-0113
work_keys_str_mv AT murayamakazuhiro differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis
AT nishiyamayuya differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis
AT hiroseyuichi differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis
AT abemasato differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis
AT ohyushigeharu differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis
AT ninomiyaayako differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis
AT fukubatakashi differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis
AT katadakazuhiro differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis
AT toyamahiroshi differentiatingbetweencentralnervoussystemlymphomaandhighgradegliomausingdynamicsusceptibilitycontrastanddynamiccontrastenhancedmrimagingwithhistogramanalysis